Page last updated: 2024-10-26

brl 42810 and Acute Promyelocytic Leukemia

brl 42810 has been researched along with Acute Promyelocytic Leukemia in 1 studies

Research Excerpts

ExcerptRelevanceReference
" We describe an occurrence of herpes zoster during treatment with arsenic trioxide (ATO) in two patients who were already in remission from acute promyelocytic leukemia and received ATO as consolidation treatment."7.72Herpes zoster during treatment with arsenic trioxide. ( Nand, S; Tanvetyanon, T, 2004)
" We describe an occurrence of herpes zoster during treatment with arsenic trioxide (ATO) in two patients who were already in remission from acute promyelocytic leukemia and received ATO as consolidation treatment."3.72Herpes zoster during treatment with arsenic trioxide. ( Nand, S; Tanvetyanon, T, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tanvetyanon, T1
Nand, S1

Other Studies

1 other study available for brl 42810 and Acute Promyelocytic Leukemia

ArticleYear
Herpes zoster during treatment with arsenic trioxide.
    Annals of hematology, 2004, Volume: 83, Issue:3

    Topics: 2-Aminopurine; Antineoplastic Agents; Antiviral Agents; Arsenic Trioxide; Arsenicals; Famciclovir; F

2004